Tezspire▼ (tezepelumab)

This is a non-promotional website produced and funded by AstraZeneca, intended for UK patients who have been prescribed TEZSPIRE▼ (tezepelumab)

Coming soon: We are currently updating this website with all relevant information for Chronic Rhinosinusitis with Nasal Polyps (CRSwNP). Please bear with us! You can access Tezspire CRSwNP resources here.

For UK patients, and their caregivers, aged 12 and over who have been prescribed Tezspire (tezepelumab) for severe uncontrolled asthma

For UK patients, and their caregivers, aged 18 and over who have been prescribed Tezspire (tezepelumab) for severe Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)

For more information read the patient information leaflet accessible here

For UK patients, and their caregivers, aged 12 and over who have been prescribed Tezspire (tezepelumab) for severe uncontrolled asthma

For UK patients, and their caregivers, aged 18 and over who have been prescribed Tezspire (tezepelumab) for severe Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)

Connect 360 is here to help you manage your condition, achieve your health goals and get the most out of your treatment with Tezspire.
The Connect 360 service helps you stay on track with your Tezspire treatment with a home delivery service, as well as to provide information on how Tezspire works and how to use it.

Tezspire should be given as an injection under the skin (subcutaneously) once every 28 days.
The injection can either be given by a doctor, nurse or carer, or you can learn how to do this yourself after proper training on the preparation and administration.

Please note: This website is here to complement the advice of your doctor, nurse or pharmacist, not to replace it.
Please always follow their instructions first and foremost and talk with them about any questions or concerns you have about your health and/or treatment.

What are you looking for today?

Discover resources to
support you on your
treatment journey

Help with
self-injection

Information about
Tezspire and why
you have been
prescribed it

Reporting side effects

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at https://yellowcard.mhra.gov.uk https://yellowcard.mhra.gov.uk. By reporting side effects, you can help provide more information on the safety of this medicine.

▼ This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get as advised above.

This is a non-promotional website produced and funded by AstraZeneca.

This site is intended to complement, not replace, the 'Instructions for Use' and 'Patient Information Leaflet' (found in your carton or linked at the top of the page). Refer to these materials for additional important information.

If you have any questions or concerns about your treatment, you should always talk to your healthcare team.

Please see the information in the box above for details on how to report any side effects you may be experiencing.